Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2022 Earnings Call Transcript February 22, 2023
Operator: Good evening. My name is Rob and I will be your conference operator today. At this time, I would like to welcome everyone to the Ligand Pharmaceuticals Fourth Quarter 2022 Earnings Webcast. Thank you. Simon Latimer, Head of Investor Relations, you may begin your conference.
Simon Latimer: Thanks, Rob. Welcome to Ligand’s fourth quarter 2022 financial results and business update...
